tiprankstipranks
Trending News
More News >
Harvard Bioscience (HBIO)
:HBIO
US Market

Harvard Bioscience (HBIO) Income Statement

Compare
273 Followers

Harvard Bioscience Income Statement

Last quarter (Q3 2025), Harvard Bioscience's total revenue was $20.59M, a decrease of -6.28% from the same quarter last year. In Q3, Harvard Bioscience's net income was $-1.23M. See Harvard Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 94.14M$ 112.25M$ 113.33M$ 118.90M$ 102.10M
Gross Profit
$ 54.77M$ 66.07M$ 60.82M$ 67.65M$ 58.04M
Operating Expenses
$ 60.98M$ 64.18M$ 67.75M$ 65.59M$ 57.82M
Depreciation and Amortization
$ 6.98M$ 7.00M$ 7.58M$ 7.62M$ 7.63M
EBITDA
$ -1.47M$ 8.03M$ 944.00K$ 9.02M$ 5.17M
Operating Income
$ -6.21M$ 1.89M$ -6.93M$ 2.07M$ 221.00K
Other Income/Expenses
$ -5.45M$ -4.45M$ -2.25M$ -2.21M$ -7.51M
Pretax Income
$ -11.66M$ -2.56M$ -9.18M$ -140.00K$ -7.29M
Net Income
$ -12.40M$ -3.42M$ -9.52M$ -288.00K$ -7.81M
Per Share Metrics
Basic EPS
$ -0.28$ -0.08$ -0.23$ -0.01$ -0.20
Diluted EPS
$ -0.28$ -0.08$ -0.23$ -0.01$ -0.20
Weighted Average Shares Outstanding
43.54M 42.42M 41.41M 40.34M 38.64M
Weighted Average Shares Outstanding (Diluted)
43.54M 42.42M 41.41M 40.34M 38.64M
Currency in USD

Harvard Bioscience Earnings and Revenue History